{
    "2019-06-25": [
        [
            {
                "time": "2019-06-25",
                "original_text": "Stocks Swing Lower As Rate Cut Optimism Dampens",
                "features": {
                    "keywords": [
                        "Rate Cut",
                        "Optimism",
                        "Dampens"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Pfizer (PFE) Flat As Market Sinks: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Flat",
                        "Market",
                        "Sinks"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "3 Healthcare Stocks to Buy With the Market Near All-Time Highs",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Buy",
                        "All-Time Highs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "After Hours Most Active for Jun 25, 2019: DIS, TI, LC, PFE, NEM, QD",
                "features": {
                    "keywords": [
                        "After Hours",
                        "Active",
                        "DIS",
                        "TI",
                        "LC",
                        "PFE",
                        "NEM",
                        "QD"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Abbvie Decides to Acquire Allergan",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Acquire",
                        "Allergan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Noteworthy ETF Inflows: SPY, BRK.B, DIS, PFE",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflows",
                        "SPY",
                        "BRK.B",
                        "DIS",
                        "PFE"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Buy",
                        "Botox-Maker",
                        "Allergan",
                        "G-20"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Dow Movers: GS, JNJ",
                "features": {
                    "keywords": [
                        "Dow",
                        "Movers",
                        "GS",
                        "JNJ"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Overpaying",
                        "Allergan",
                        "Pfizer",
                        "Offered",
                        "2015"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Pfizer’s Oncology Treatment Growth Drivers",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Oncology",
                        "Treatment",
                        "Growth",
                        "Drivers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Comparing PFE’s and BMY’s Expense Trends",
                "features": {
                    "keywords": [
                        "PFE",
                        "BMY",
                        "Expense",
                        "Trends"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "How PFE’s and BMY’s EPS Trends Compare",
                "features": {
                    "keywords": [
                        "PFE",
                        "BMY",
                        "EPS",
                        "Trends",
                        "Compare"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Allergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal",
                "features": {
                    "keywords": [
                        "Allergan",
                        "surges",
                        "news",
                        "Abbvie",
                        "buy",
                        "Botox",
                        "$63 billion",
                        "deal"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}